Top View
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- 2019 Table of Drugs
- Department of Human Services IOWA Medicaid Program Draft PDL for March 9, 2006 P & T Committee Meeting PDL DRUG LIST (Two Drug Columns)
- Medicines (Prescription Only) (Jersey) Order 1997
- Division of Vital Statistics, Mortality Data Table Page 1 of 147
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Of Authors' Names
- N-Acetylcysteine and Sodium 2-Mercaptoethane Sulfonate As Sources of Urinary Thiol Groups in the Rat1
- TP Information on ANTIDOTES
- Market Shortage Items That Are Allocated by the Manufacturer Date: 4/17/2020 *Allocation Types Are Either "W" Weekly Or "M" Monthly
- Proposal for the Inclusion of Mesna (Sodium 2-Mercaptoethane Sulfonate)
- Alphabetical Listing by Therapeutic Category Dod UNIFORM
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Atc Index 2010
- CPT/HCPCS Medication Code Reference List
- Combined Index to USP 42 and NF 37, Volumes 1–5, Including Second Supplement
- N-Acetylcysteine Rescue Protocol for Nephrotoxicity in Children Caused by Ifosfamide
- Jiangsu Hengrui Medicine Co., Ltd., Established in 1970, Having Over 13,000 Employees Globally, Is the Largest Manufacturer of Antineoplastics in China
- A Pharmaceutical Composition Comprising a Menthane Carboxylic Acid Amide
- Extended Stability for Parenteral Drugs, 5Th Edition
- DRUG NAME: Cisplatin
- Health Net Cal Mediconnect Plan (Medicare-Medicaid Plan) 0%S.O 0( XQ.B 0QN%& =(O." Q& 2015 ?
- High Dose Conditioning with Ifosfamide, Carboplatin, and Etoposide with Autologous Stem Cell Transplantation for Patients with Recurrent Nasopharyngeal Carcinoma
- 1 (Emergency Drug) FF (Antidote)
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- Similar Bioavailability of Single-Dose Oral and Intravenous Mesna in the Blood and Urine of Healthy Human Subjects’
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Pharmacokinetics and Therapeutic Uses of Mesna
- Customs Tariff - Schedule Xxi - 1
- Mesna) Injection, for Intravenous Use • Hypersensitivity Reactions: Anaphylactic Reactions Have Been Reported
- Pharmacology/Toxicology Case Studies
- Principles of Antineoplastic Therapy
- FIXED DOSE COMBINATIONS APPROVED by DCG (I) SINCE 1961 TILL 20Th December 2018
- Gold Standard Drug Monographs
- Guidelines for ATC Classification and DDD Assignment 2021
- R-ICE NOTE: There Is a Modified RICE Protocol Which Must Be Used Within Oxford Due to Stability Restrictions with Baxter Aseptically Manufactured Ifosfamide
- Guidelines for ATC Classification and DDD Assignment 2011
- AHFS Pharmacologic-Therapeutic Classification System
- ICD-10-CM TABLE of DRUGS and CHEMICALS
- FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
- 2020 Table of Drugs
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- DRUG NAME: Mesna
- Sudan National Essential Medicines List
- (19) United States (12) Patent Application Publication (10) Pub
- (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
- AIM (Doxorubicin + Ifosfamide +
- Drugs and Pharmaceuticals: Management of Intoxication and Antidotes
- Abstract This Material Provides Documentation for Users of The
- N-Acetylcysteine As a Chemoprotectant Against Ifosfamide Nephrotoxicity; from Mechanism to Prevention
- Restrictions in Use and Availability of Pharmaceuticals 2010 - 2018
- Resolution Ap (2000) 1
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- The Prescription Only Medicines (Human Use) Order 1997
- Kansas Medical Assistance Program Provider Manual
- Effective 07-01-2021) the Florida Medicaid Preferred Drug List (PDL